Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair Greg Stratmann, MD, PhD, Isobel A Russell,

Slides:

Advertisements

Similar presentations

Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J

Advertisements

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Effect of Hospital Culture on Blood Transfusion in Cardiac Procedures

Contemporary Bloodletting in Cardiac Surgical Care

Warfarin therapy does not increase bleeding in patients undergoing heart transplantation Cullen D Morris, MD, J.David Vega, MD, Jerrold H Levy, MD, Nancy.

Amit Iyengar, Christopher N. Scipione, MD, Parth Sheth, Richard G

Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program Steve Xydas, MD, Christopher.

Gaetano Paone, MD, MHSA, Robert Brewer, MD, MHSA, Donald S

Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: A prospective randomized study Raimondo Ascione,

Morbidity of Bleeding After Cardiac Surgery: Is It Blood Transfusion, Reoperation for Bleeding, or Both? Alessandro Vivacqua, MD, Colleen G. Koch, MD,

Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J

Off-pump epicardial tissue sealing—a novel method for atrioventricular disruption complicating mitral valve procedures Albert Schuetz, MD, PhD, Costas.

LiQian Chen, MD, PhD, Arthur W

Autologous Platelet-Rich Plasma Reduces Transfusions During Ascending Aortic Arch Repair: A Prospective, Randomized, Controlled Trial Shao Feng Zhou,

Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.

Total Arch Replacement Under Normothermic Beating Heart Surgery

James L Zellner, MD, Scott B Kribbs, BS, B

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Aprotinin and Dipyridamole for the Safe Reduction of Postoperative Blood Loss Gideon Cohen, Joan Ivanov, Richard D Weisel, Vivek Rao, Molly K Mohabeer,

Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.

Sivelestat Attenuates Lung Injury in Surgery for Congenital Heart Disease With Pulmonary Hypertension Norikazu Nomura, MD, PhD, Miki Asano, MD, PhD,

Theodore C Koutlas, MD, Joseph R Elbeery, MD, J

Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients Faraz Kerendi, MD, John D. Puskas,

Current determinants of operative mortality in 1400 patients requiring aortic valve replacement Ines Florath, PhD, Ulrich P Rosendahl, MD, Amir Mortasawi,

Transfusion Increases the Risk for Vasoplegia After Cardiac Operations

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements E. Schaden, O. Kimberger, P. Kraincuk, D.M.

Surgical treatment of the dilated ascending aorta: when and how?

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Richard S. D’Agostino, MD, Jeffrey P

James D. St. Louis, MD The Annals of Thoracic Surgery

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis

Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest Jennifer M. Hanna, MD, MBA, Jeffrey.

Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery Lyndsey J. Bowman, Walter E.

Stapling of an aortic arch aneurysm

Does moderate hypothermia really carry less bleeding risk than deep hypothermia for circulatory arrest? A propensity-matched comparison in hemiarch replacement

Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

Risks and Predictors of Blood Transfusion in Pediatric Patients Undergoing Open Heart Operations Andrea Székely, MD, PhD, Zsuzsanna Cserép, MD, Erzsébet.

Are older patients with mechanical heart valves at increased risk?

Zoe K. McQuilten, MBBS, Nick Andrianopoulos, MBBS, MBiostat, Erica M

Bleeding and management of coagulopathy

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: Results from.

Effect of Hospital Culture on Blood Transfusion in Cardiac Procedures

Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A

Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: Clinical and economic outcomes Walter.

Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest Judson B. Williams, MD, Barbara Phillips-Bute,

Red Blood Cell Transfusion Is Associated With Troponin Release After Elective Off- Pump Coronary Artery Bypass Surgery Fausto Biancari, MD, PhD, Eeva-Maija.

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Individualized heparin and protamine management in infants and children undergoing cardiac operations Massimiliano Codispoti, MD, Christopher A Ludlam,

Safety and efficacy of a heparin removal device: a prospective randomized preclinical outcomes study Joseph B Zwischenberger, MD, Weike Tao, MD, Donald.

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary.

No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits Christian Olsson, MD, Agneta Siegbahn, MD, PhD,

Damage control surgery in the era of damage control resuscitation

Stany Sandrio, MD, Ariawan Purbojo, MD, Robert A

Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery Scott B Chelemer, MD, B.Stephen Prato, MA, Paul.

Michael W. A. Chu, MD, Steve R. Wilson, BS, Richard J

Minimal access aortic valve replacement: effects on morbidity and resource utilization Nicolas Doll, MD, Michael A Borger, MD, PhD, Joerg Hain, Jan Bucerius,

Bleeding Complications and Blood Product Utilization With Left Ventricular Assist Device Implantation Justin M. Schaffer, MS, George J. Arnaoutakis,

Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost Michael J Ray, PhD, Mark F O’Brien

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations William C Oliver, MD, Paula J Santrach, MD, Gordon.

Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Victor O. Morell, MD, Peter A.

Joseph S Coselli, MD, Lori D Conklin, MD, Scott A LeMaire, MD

Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions Ruth L Taylor, MSc, Michael A Borger, MD, Richard.

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Safety of low hematocrits during cardiopulmonary bypass

Thrombophilic Variables Do Not Increase the Generation or Procoagulant Activity of Thrombin During Cardiopulmonary Bypass Peter Raivio, MD, Jari Petäjä,

Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm.

Hemostasis Alterations in Patients With Acute Aortic Dissection

Presentation transcript:

Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair Greg Stratmann, MD, PhD, Isobel A Russell, MD, PhD, Scott H Merrick, MD The Annals of Thoracic Surgery Volume 76, Issue 6, Pages 2094-2097 (December 2003) DOI: 10.1016/S0003-4975(03)01052-X

Fig 1 Transfusion timeline: Transfusion events during aortic arch replacement. The initial transfusion event occurred during an episode of torrential bleeding from the aorta during thoracotomy. The following events occurred during initial attempts of separation from CPB and the subsequent CPB period. The final event occurred after administration of protamine. Importantly, although not illustrated in this figure, the infusion of 11,000 mL of “cell saver blood” over the 90 minutes following separation from CPB contributed significantly to meeting this patient's transfusion requirements. (CPB = cardiopulmonary bypass; cryo = cryoprecipitate; ffp= fresh frozen plasma; plt= platelets; prbc= packed red blood cells.) The Annals of Thoracic Surgery 2003 76, 2094-2097DOI: (10.1016/S0003-4975(03)01052-X)